Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...
Roche RHHBY announced that it will acquire clinical-stage biopharmaceutical company Poseida Therapeutics, Inc. PSTX for $9 ...
News Medical on MSN4h
Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALLPatients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback